Patient Capital Management portfolio
Concentrated managerInvestment firmPortfolio as of Jun 30, 2026 (Q2 2026) · filed with the SEC on Aug 13, 2026 · data updated on Nov 5, 2026 · Q2 2026 13F (filing) ↗ · all its 13F filings ↗
A 13F shows the portfolio at quarter-end and is filed up to 45 days later: these are not real-time positions and they may have changed.
Patient Capital Management reported a $3.0 bn portfolio of 39 positions to the SEC as of the end of Q2 2026. Its largest positions are RPRX, C, GOOGL. During the quarter it opened Global Payments and exited Ishares Bitcoin Trust ETF.
Sections with a free account
What changed this quarter
30 positions with a change (2 new, 9 added to, 18 trimmed, 1 sold). 7 are listed here: those of 0.5 points of the portfolio or more (up to 12).
- Global Payments+2.3 ppof portfolioNew— → 2.3%
- Noble−93%fewer sharesReduced2.5% → 0.1%
- Fidelity Wise Origin Bitcoin+244%more sharesIncreased0.8% → 2.1%
- Ishares Bitcoin Trust ETF−1.4 ppof portfolioSold out1.6% → —
- Illumina−37%fewer sharesReduced2.5% → 2.0%
- Chime Financial+42%more sharesIncreased2.0% → 2.8%
- Biogen−25%fewer sharesReduced2.6% → 2.0%
The figure on the right: for positions added to or trimmed, the change in the number of shares (%); for new and sold ones, the points of the portfolio moved (pp). Below, the portfolio weight before → after. Traded weight: what it bought or sold, excluding price effects.
Top holdings
- Royalty PharmaRPRX6.7%
- CitigroupC6.5%
- AlphabetGOOGL6.2%
- UnitedHealth GroupUNH6.0%
- Amazon.comAMZN5.4%
- NVIDIANVDA4.7%
- CVS HealthCVS4.2%
- Norwegian Cruise Line HoldingsNCLH4.2%
- QXOQXO4.1%
- Energy TransferET3.9%
- PeoplePPLI3.7%
- PrecigenPGEN3.6%
- United Airlines HoldingsUAL3.3%
- CrocsCROX3.2%
- Meta PlatformsMETA3.2%
“Since”: first quarter of the current run, unbroken until today. In the details, prices are the quarter-end prices of the quarters in which it added shares, per the 13F. The manager may have bought at any price within each quarter; the SEC only publishes the value at quarter end.
Portfolio by sector
- ● Health Care 25%
- ● Financials 20%
- ● Consumer Discretionary 17%
- ● Communication Services 13%
- ● Industrials 9%
- ● Information Technology 7%
- ● Energy 6%
- ● No sector 2%
How its portfolio changed (8 quarters)
Q2 2026: 39
Q2 2026: 52%
Q2 2026: 7.1%
Traded turnover: the weight it bought plus the weight it sold in the quarter, divided by two, excluding price moves. The plain “turnover” in the header does include that effect. With a free account: the full history and sectors over time.
Declared options (1)
Besides stocks, Patient Capital Management declared 1 call (they gain if it rises) with a notional of $40.9M. The 13F reports the value of the underlying shares, not the premium paid, so these figures look large and are not added to the portfolio. Nor does it say whether the option is bought or written, or its strike or expiry: it may be a hedge.
- CALLBiogenBIIB$40.9M
Stakes above 5% (13D/13G)
Companies where this filer reported holding 5% or more of the shares. It is the figure from its latest filing on each one; history since December 2024.
How we classify it
Investment firm, per its Form ADV of Mar 27, 2026 (high confidence).
The data, as reported: PATIENT CAPITAL MANAGEMENT, LLC (CRD 307336): Manages registered funds; 5.D assets by client type: registered funds 74%, governments 12%, pooled vehicles 8% (of $2.5 bn)
The type comes from a rule applied to that data. If it looks wrong, tell us.
Similar managers by type and size
Same type of filer and a 13F portfolio value between a third and three times this one. It is not a comparison of what they hold.
- L1 Capital PtyInvestment firm · $3.0 bn
- Giverny CapitalInvestment firm · $3.0 bn
- Hawk Ridge Capital ManagementInvestment firm · $3.1 bn
- Palestra Capital ManagementInvestment firm · $2.9 bn
- Caledonia (Private) Investments PtyInvestment firm · $2.9 bn
- BIT Capital GmbHInvestment firm · $2.9 bn